Allergan - Obesity Intervention Division's Unit Acquisition

Allergan - Obesity Intervention Division raised a round of funding on December 02, 2013. Investors include Apollo Endosurgery.

Allergan is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter consumer products t…

Articles about Allergan - Obesity Intervention Division's Unit Acquisition: